Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model.

Kim A PappAhmed M SolimanNicolae DoneChristopher CarleyEsteban Lemus WirtzLuis Puig

Published in: Dermatology and therapy (2021)

The predicted DLQI score deteriorated more rapidly after risankizumab withdrawal than the PASI score, an objective measure of disease. These findings suggest that the deterioration in HRQL reflects more substantial impacts after risankizumab discontinuation than those measured by PASI only.

Keyphrases

machine learning
coronary artery disease
artificial intelligence
early onset
big data
smoking cessation